IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC)

Name: IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC)
License: Public Domain

Innovent Biologics (Suzhou) Co. Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

nsclc (non-small-cell lung cancer)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 394766
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.